| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/15/2010 | WO2010080913A1 Cyclosporine compositions for enhancing nail growth |
| 07/15/2010 | WO2010080765A2 High-throughput production of ingestible event markers |
| 07/15/2010 | WO2010080764A2 Pharmaceutical dosages delivery system |
| 07/15/2010 | WO2010080754A2 Nanoparticle pharmaceutical formulations |
| 07/15/2010 | WO2010080730A2 Methods and materials for delivering bile acids |
| 07/15/2010 | WO2010080724A1 Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| 07/15/2010 | WO2010080652A1 Chlorhexidine acetate antiseptic cleaning agent |
| 07/15/2010 | WO2010080622A1 Drug delivery devices for delivery of therapeutic agents |
| 07/15/2010 | WO2010080580A2 Extended-release pharmaceutical formulations |
| 07/15/2010 | WO2010080339A1 Phenylephrine formulations with improved stability |
| 07/15/2010 | WO2010079978A2 Composition for improving inflammatory disease using abh antigens |
| 07/15/2010 | WO2010079373A1 Improved pharmaceutical formulation |
| 07/15/2010 | WO2010079343A2 Formulations of viable cells for oral delivery |
| 07/15/2010 | WO2010079310A1 Pharmaceutical composition containing malathion and a volatile cyclic silicone |
| 07/15/2010 | WO2010079287A1 Divisible tablet containing particles coated with s-adenosyl-methionine |
| 07/15/2010 | WO2010079222A1 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| 07/15/2010 | WO2010079221A1 Pharmaceutical composition comprising one or more fumaric acid esters |
| 07/15/2010 | WO2010079052A2 Nanoparticle compositions |
| 07/15/2010 | WO2010079047A2 Octreotide depot formulation with constantly high exposure levels |
| 07/15/2010 | WO2010078941A1 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy |
| 07/15/2010 | WO2010078935A2 Solutions for volume therapy |
| 07/15/2010 | WO2010078911A1 Antiviral patch |
| 07/15/2010 | WO2010078878A1 Duloxetine formulations |
| 07/15/2010 | WO2010078675A1 The drug delivery vehicle using gold-magnetic composite particles coated by polysaccharides and its preparation |
| 07/15/2010 | WO2010057214A3 Nanoparticles and porous particles and methods of making the same |
| 07/15/2010 | WO2010054654A4 Modified cationic liposome adjuvans |
| 07/15/2010 | WO2010048610A3 Compositions and methods for promoting bone formation |
| 07/15/2010 | WO2010048478A3 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates |
| 07/15/2010 | WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 07/15/2010 | WO2010044108A3 Controlled release formulations of ropinirole |
| 07/15/2010 | WO2010039762A3 Pharmaceutical compositions comprising boronic acid compounds |
| 07/15/2010 | WO2010036904A3 Preparation of valganciclovir and its salts |
| 07/15/2010 | WO2010023693A3 Controlled release compositions of ropinirole |
| 07/15/2010 | WO2010020772A3 Sore throat compositions |
| 07/15/2010 | WO2010015567A3 Controlled release formulations using intelligent polymers |
| 07/15/2010 | WO2010013250A3 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof |
| 07/15/2010 | WO2009158412A3 Sustained delivery of exenatide and other polypeptides |
| 07/15/2010 | WO2009156743A3 Magnetic microbubbles, methods of preparing them and their uses |
| 07/15/2010 | WO2009130181A3 Dry transglutaminase composition |
| 07/15/2010 | WO2009076141A8 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/15/2010 | WO2008140853A3 Water dispersible polymer compositions |
| 07/15/2010 | US20100179182 Pharmaceutical formulation |
| 07/15/2010 | US20100178648 In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions |
| 07/15/2010 | US20100178354 Remedy |
| 07/15/2010 | US20100178353 Quick dissolve compositions and tablets based thereon |
| 07/15/2010 | US20100178352 Uniformly abrasive confectionery product and process therefor |
| 07/15/2010 | US20100178350 Amino-acid-containing medicinal granular preparation highly easy to take |
| 07/15/2010 | US20100178349 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 07/15/2010 | US20100178348 Myostatin Inhibition for Enhancing Muscle and/or Improving Muscle Function |
| 07/15/2010 | US20100178347 Method of treating traumatic brain injury |
| 07/15/2010 | US20100178346 Disc augmentation with hyaluronic acid |
| 07/15/2010 | US20100178345 Hydrogel Microparticle Composition, Application Thereof and Method for Preparing the Same |
| 07/15/2010 | US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles |
| 07/15/2010 | US20100178343 Storage-stable laminate segments |
| 07/15/2010 | US20100178342 Solid Pharmaceutical Preparation |
| 07/15/2010 | US20100178341 BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR |
| 07/15/2010 | US20100178340 Tableted compositions containing atazanavir |
| 07/15/2010 | US20100178339 Tableted compositions containing atazanavir |
| 07/15/2010 | US20100178338 Stabilized pharmaceutical compositions comprising atorvastatin |
| 07/15/2010 | US20100178337 Composition comprising an active agent with low aqueous solubility |
| 07/15/2010 | US20100178336 Stabilized amorphous forms of imatinib mesylate |
| 07/15/2010 | US20100178335 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 07/15/2010 | US20100178334 Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid |
| 07/15/2010 | US20100178333 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 07/15/2010 | US20100178332 Cellulose-based fine core particle and process for producing the same |
| 07/15/2010 | US20100178331 Preparation for transnasal application |
| 07/15/2010 | US20100178330 Asymmetric liposomes and uses in medical field thereof |
| 07/15/2010 | US20100178329 Liposome composition |
| 07/15/2010 | US20100178328 Combination therapy for ovarian cancer |
| 07/15/2010 | US20100178327 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients |
| 07/15/2010 | US20100178326 Aminophosphonate carriers for liposome-based drug release systems |
| 07/15/2010 | US20100178325 Amphiphilic nucleotide cochleate compositions and methods of using the same |
| 07/15/2010 | US20100178324 Composition and method for the treatment of diseases affected by apoptosis |
| 07/15/2010 | US20100178323 Dermal Delivery Device |
| 07/15/2010 | US20100178322 Adhesive preparation and patch preparation |
| 07/15/2010 | US20100178321 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 07/15/2010 | US20100178320 New medical products |
| 07/15/2010 | US20100178319 Topical Dermal Delivery Device For Nitric Oxide Delivery |
| 07/15/2010 | US20100178318 Composite Structure Including A Low Vinyl Acetate Layer |
| 07/15/2010 | US20100178315 Polymeric systems for controlled drug therapy |
| 07/15/2010 | US20100178314 Freeze-dried fibrin matrices and methods for preparation thereof |
| 07/15/2010 | US20100178313 Implantable Degradable Biopolymer Fiber Devices |
| 07/15/2010 | US20100178307 Transdermal anti-dementia active agent formulations and methods for using the same |
| 07/15/2010 | US20100178306 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 07/15/2010 | US20100178305 Ultrasonic nanotherapy of solid tumors with block copolymers stabilized perfluorocarbon nanodroplets |
| 07/15/2010 | US20100178304 Method for silk fibroin gelation using sonication |
| 07/15/2010 | US20100178255 Composition and method to treat otitis media and ventilator- associated pneumonia |
| 07/15/2010 | US20100178254 Unit assembly for multiple film dosages, apparatus, and methods |
| 07/15/2010 | US20100178250 Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | DE102009026243A1 Textilfaser oder -fäden mit Einlagerungen für die kombinierte Applikation von Naturheilstoffen und elektromagnetischen Strahlungen Textile fibers or filaments with retention for the combined application of natural curatives and electromagnetic radiation |
| 07/15/2010 | DE102005058569B4 Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer Foam wafer with polyvinyl alcohol-polyethylene glycol graft |
| 07/15/2010 | CA2782655A1 Nanoparticle pharmaceutical formulations |
| 07/15/2010 | CA2750151A1 High-throughput production of ingestible event markers |
| 07/15/2010 | CA2750148A1 Pharmaceutical dosages delivery system |
| 07/15/2010 | CA2749143A1 Compositions for enhancing nail growth |
| 07/15/2010 | CA2749141A1 Cyclosporine compositions for enhancing nail growth |
| 07/15/2010 | CA2749099A1 Method for treating hyperglycemia with glp-1 |
| 07/15/2010 | CA2748827A1 Composition and method for treatment of diabetes |
| 07/15/2010 | CA2747680A1 Solutions for volume therapy |